It was shown to activate the MAPK and JNK signalling pathways and cause breast cancer resistance to tamoxifen [48]; its cytoplasmic concentration was shown to be a negative sign for the treatment of invasive breast cancer [49]. Here, MAPK8 is linked to breast carcinoma.